In Vitro Hemostatic Properties of French Lyophilized PlasmaMARTINAUD, Christophe; CIVADIER, Corinne; AUSSET, Sylvain et al.Anesthesiology (Philadelphia). 2012, Vol 117, Num 2, pp 339-346, issn 0003-3022, 8 p.Article

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over timePIDCOKE, Heather F; MCFAUL, Steve J; ADEN, James K et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 1, issn 0041-1132, S137-S149, SUPConference Paper

New hemostatic agents in the combat settingCOX, E.Darrin; SCHREIBER, Martin A; MCMANUS, John et al.Transfusion (Philadelphia, PA). 2009, Vol 49, Num 5, issn 0041-1132, 248S-255S, SUPArticle

Hemostatic agentsLEVY, Jerrold H.Transfusion (Philadelphia, PA). 2004, Vol 44, Num 12, pp 58S-62S, issn 0041-1132, SUPConference Paper

Antithrombin Affects Hemostatic Response to Recombinant Activated Factor VII in Factor VIII Deficient PlasmaSZLAM, Fania; TAKETOMI, Taro; SHEPPARD, Chelsea A et al.Anesthesia and analgesia. 2008, Vol 106, Num 3, pp 719-724, issn 0003-2999, 6 p.Article

Primary and secondary hemostatic functionalities of rehydrated, lyophilized plateletsFISCHER, Thomas H; BODE, Arthur P; PARKER, Benjamin R et al.Transfusion (Philadelphia, PA). 2006, Vol 46, Num 11, pp 1943-1950, issn 0041-1132, 8 p.Article

The relationship between cardiometabolic and hemostatic variables : influence of racePERRY, Arlette; XUEWEN WANG; GOLDBERG, Ronald et al.Metabolism, clinical and experimental. 2008, Vol 57, Num 2, pp 200-206, issn 0026-0495, 7 p.Article

Meta-analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen-reduced plateletsYAMVAKAS, Eleftherios C.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 5, pp 1058-1071, issn 0041-1132, 14 p.Article

Fibrinogen prepared from small blood samples for autologous use in a tisoue adhesive systemSIVERTSEN WEIS-FOGH, U.European surgical research. 1988, Vol 20, Num 5-6, pp 381-389, issn 0014-312XArticle

Hemostatic effect of n-butyl-2-cyanoacrylate (histoacryl) glue in warfarin-treated patients undergoing oral surgeryAL-BELASY, Fouad A; AMER, Maged Z.Journal of oral and maxillofacial surgery. 2003, Vol 61, Num 12, pp 1405-1409, issn 0278-2391, 5 p.Article

Fibrin sealant : current and potential clinical applicationsJACKSON, M. R; MACPHEE, M. J; DROHAN, W. N et al.Blood coagulation & fibrinolysis. 1996, Vol 7, Num 8, pp 737-746, issn 0957-5235Article

Use of fibrin glue as a hemostatic in endoscopic sinus surgeryVAIMAN, Michael; SHLAMKOVICH, Nathan; EVIATAR, Ephraim et al.The Annals of otology, rhinology & laryngology. 2005, Vol 114, Num 3, pp 237-241, issn 0003-4894, 5 p.Article

Fibrin sealant : A review of its use in surgery and endoscopyDUNN, C. J; GOA, K. L.Drugs (Basel). 1999, Vol 58, Num 5, pp 863-886, issn 0012-6667Article

Superficial partial thickness (2nd degree) burn from zeolite mineral hemostatic agent (QuickClot)HURTADO, Timothy R; WISENBAUGH, Thomas.Annals of emergency medicine. 2005, Vol 46, Num 3, issn 0196-0644, p. 297Article

Reducing hemostatic activation during cardiopulmonary bypass: A combined approachEISSES, Michael J; SEIDEL, Kristy; ALDEA, Gabriel S et al.Anesthesia and analgesia. 2004, Vol 98, Num 5, pp 1208-1216, issn 0003-2999, 9 p.Article

Novel hemostatic alternatives in reconstructive surgeryWANER, Milton.Seminars in hematology. 2004, Vol 41, Num 1, pp 163-167, issn 0037-1963, 5 p., SUP1Conference Paper

Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhageMICHAEL FITZPATRICK, G; CLIFF, Richard; TANDON, Narendra et al.Transfusion (Philadelphia, PA). 2013, Vol 53, Num 1, issn 0041-1132, S100-S106, SUPConference Paper

Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technologyOSTROWSKI, Sisse R; BOCHSEN, Louise; WINDELOV, Nis A et al.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 2, pp 344-356, issn 0041-1132, 13 p.Article

Les agents hémostatiques chirurgicaux en pratique = Hemostatic agents in surgery in practiceLe Pharmacien hospitalier. 2008, Vol 43, issn 0768-9179, 22 p., HS1Serial Issue

Hemostatic therapy revisitedHORROW, J. C.Anesthesiology clinics of North America. 1994, Vol 12, Num 1, pp 91-117, issn 0889-8537Article

Prospective Longitudinal Study of Thromboelastography and Standard Hemostatic Laboratory Tests in Healthy Women During Normal PregnancyKARLSSON, Ove; SPORRONG, Tommy; HILLARP, Andreas et al.Anesthesia and analgesia. 2012, Vol 115, Num 4, pp 890-898, issn 0003-2999, 9 p.Article

Good manufacturing practice-grade fibrin gel is useful as a scaffold for human mesenchymal stromal cells and supports in vitro osteogenic differentiationTROMBI, Luisa; D'ALESSANDRO, Delfo; PACINI, Simone et al.Transfusion (Philadelphia, PA). 2008, Vol 48, Num 10, pp 2246-2251, issn 0041-1132, 6 p.Article

An efficient method for the application of Avitene® hemostatic agentDECKER, C. J.Surgery, gynecology & obstetrics. 1991, Vol 172, Num 6, issn 0039-6087, p. 489Article

Platelet procoagulant activity : physiological significance and mechanisms of exposureBEVERS, E. M; COMFURIUS, P; ZWAAL, R. F. A et al.Blood reviews. 1991, Vol 5, Num 3, pp 146-154, issn 0268-960XArticle

Hemostatic effects of fibrinogen γ-chain dodecapeptide-conjugated polymerized albumin particles in vitro and in vivoOKAMURA, Yosuke; TAKEOKA, Shinji; TERAMURA, Yuji et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 7, pp 1221-1228, issn 0041-1132, 8 p.Article